Application Nr Approved Date Route Status External Links
ANDA090440 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Famotidine For Oral Suspension Is Indicated In Adults For The Treatment Of: Active Duodenal Ulcer (Du). Active Gastric Ulcer (Gu). Symptomatic Nonerosive Gastroesophageal Reflux Disease (Gerd). Erosive Esophagitis Due To Gerd, Diagnosed By Biopsy. Treatment Of Pathological Hypersecretory Conditions (E.g., Zollinger-Ellison Syndrome, Multiple Endocrine Neoplasias). Reduction Of The Risk Of Duodenal Ulcer Recurrence. Famotidine For Oral Suspension Is Indicated In Pediatric Patients 1 Year Of Age And Older For The Treatment Of: Peptic Ulcer Disease. Gerd With Or Without Esophagitis And Ulcerations. Famotidine For Oral Suspension Is Indicated In Pediatric Patients From Birth To Less Than 1 Year Of Age For The Treatment Of: Gerd. Famotidine For Oral Suspension Is A Histamine-2 (H2) Receptor Antagonist Indicated ( 1 ): In Adults For The Treatment Of: Active Duodenal Ulcer (Du). Active Gastric Ulcer (Gu). Symptomatic Nonerosive Gastroesophageal Reflux Disease (Gerd). Erosive Esophagitis Due To Gerd, Diagnosed By Biopsy. Treatment Of Pathological Hypersecretory Conditions (E.g., Zollinger-Ellison Syndrome, Multiple Endocrine Neoplasias). Reduction Of The Risk Of Du Recurrence. In Pediatric Patients 1 Year Of Age And Older For The Treatment Of: Peptic Ulcer Gerd With Or Without Esophagitis And Ulcerations In Pediatric Patients From Birth To Less Than 1 Year Of Age For The Treatment Of: Gerd.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Famotidine FAMOTIDINE ZINC1530636

Comments